Salivary Gland Pleomorphic Adenoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
63
|
9
|
0.600 |
None |
0.941 |
17 |
|
1996 |
2019 |
Lipoblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
20
|
|
0.400 |
None |
1.000 |
21 |
|
2000 |
2020 |
Russell-Silver syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
104
|
12
|
0.400 |
strong |
1.000 |
1 |
2
|
2018 |
2018 |
MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
32
|
8
|
0.300 |
strong |
1.000 |
1 |
|
2018 |
2018 |
Lipoblastomatosis
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Radiolabeled somatostatin analog study
|
phenotype |
|
Diagnostic Procedure
|
3
|
|
0.300 |
strong |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.100 |
None |
0.966 |
563 |
2
|
1991 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
0.968 |
558 |
2
|
1994 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.937 |
189 |
|
1994 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.962 |
78 |
|
1999 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.956 |
68 |
|
1999 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.981 |
54 |
|
1999 |
2019 |
Mixed Salivary Gland Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
185
|
3
|
0.100 |
None |
0.974 |
39 |
|
1998 |
2020 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.100 |
None |
0.970 |
33 |
|
1996 |
2020 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.100 |
None |
1.000 |
31 |
|
1995 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.857 |
21 |
|
2003 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
1.000 |
18 |
|
2006 |
2019 |
Secondary malignant neoplasm of bone
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
647
|
18
|
0.100 |
None |
0.941 |
17 |
|
2011 |
2019 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.100 |
None |
0.941 |
17 |
|
2012 |
2020 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
1.000 |
16 |
|
2013 |
2019 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.100 |
None |
0.933 |
15 |
|
2008 |
2020 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.100 |
None |
1.000 |
11 |
|
1999 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.100 |
None |
0.909 |
11 |
|
2000 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.909 |
11 |
|
2004 |
2017 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.100 |
None |
0.700 |
10 |
|
1994 |
2019 |